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We report the draft genome sequence ofMycobacterium obuense strain UC1 from a patient sputum sample. This is the first draft
genome sequence ofMycobacterium obuense, a rapidly growing scotochromogenic mycobacterium.
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Mycobacterium obuense is a rapidly growing scotochromoge-nic member of the genus Mycobacterium that has been
previously isolated from soil and the sputum of a patient with
pulmonary disease (1). The unique biochemical properties of
M. obuense that resulted in it being classified as a species include its
ability to degrade p-aminosalicylate and salicylate into black prod-
ucts. Smooth colonies of this species have been reported to be
mobile, along with several other environmental mycobacteria (2).
A heat-killed suspension of M. obuense has been investigated as a
potential treatment for melanoma due to its stimulation of anti-
tumor T cell response (3, 4).
Rapidly growingmycobacteria constitute a commonly isolated
population of acid-fast bacilli in the clinical microbiology lab of
varying clinical importance (5). Their speciation via molecular
methods is becoming increasingly important given the expanding
numbers of immunosuppressed individuals in which they can be
pathogenic. We sequenced the first draft genome of Mycobacte-
rium obuense in order to enhancemolecular methods of detection
and to understand mycobacterial genetic diversity.
The patient had a history of non–small cell lung cancer and
presented with patchy lung infiltrates. A sputum culture for acid-
fast bacilli yielded a rapidly growing scotochromogen identified
by high-performance liquid chromatography as M. obuense/
M. aurum. DNA from isolated colonies of strain UC1 was ex-
tracted using the Qiagen EZ1 DNA tissue kit and paired-end li-
braries were prepared using the Nextera XT DNA library kit
followed by sequencing on the Illumina MiSeq. Sequences were
adapter and quality (Q20) trimmed using cutadapt, de novo as-
sembled using SPAdes version 3.5, metagenomically screened
with SURPI, and annotated with Prokka version 1.1 (6–9). A total
of 10,848,516 paired-end reads of average length 111.7 nucleo-
tides were recovered after trimming.Denovo assembly yielded 249
contigs500 nucleotides for a total assembly size of 6,382,135 bp
with anN50 of 55,467 bp, an average coverage of 148, and a total
of 6,193 coding sequences. Contiguity was most likely disrupted
by high GC content (68%), and several high-copy-number inte-
grases and transposases longer than the sequence read length. Of
note, three contigs18 kb each demonstrated 4higher coverage
than other sequences and aligned to plasmids present in M. ab-
scessus strains with approximately 80% identity, suggesting that
the UC1 strain has one or more plasmids.
Pairwise alignment of available sequenced genes from Myco-
bacterium obuense type strain CIP 106803 (16S, hsp65, gyrB, rpoB,
sod) with strain UC1 revealed 99 to 100% identity, confirming the
identify as Mycobacterium obuense. The closest related complete
genome to M. obuense UC1 was Mycobacterium chubuense NBB4
(81.3% identity), while the closest NCBIWGS database entry was
Mycobacterium rufum JS14 (92.2% identity). Analysis by the
Comprehensive Antibiotic Resistant Database identified putative
resistance genesmarA (55% amino acid identity to Frankia spp.),
aminoglycoside resistance protein/kinase (62% amino acid iden-
tity to M. rufum JS14), two metallo-beta-lactamases (86% and
89% amino acid identity to M. rufum JS14), blaF beta-lactamase
(79% amino acid to M. rufum JS14), and beta-lactamase (43%
amino acid to Gordonia spp.) (10, 11).
Nucleotide sequence accessionnumbers.Thiswhole-genome
shotgun project has been deposited at DDBJ/ENA/GenBank un-
der the accession number LAUZ00000000. The version described
in this paper is the second version, LAUZ02000000.
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